Kesoram Industries Limited has informed the Exchange about disclosure for reason for encumbrance under SEBI Takeover Regulations, 2011.
Fino Payments Bank Limited has informed the Exchange about Transcript
Larsen & Toubro Limited has informed the Exchange regarding Scheme of Arrangement for Amalgamation of L&T Hydrocarbon Engineering Limited ( LTHE ) with Larsen & Toubro Limited ( L&T ).
DRC Systems India Limited has informed the Exchange regarding Updates on Acquisition.
Meghmani Organics Limited has informed the Exchange regarding Board meeting held on February 02, 2022.
Coromandel International Limited has informed the Exchange about Schedule of meet
Suven Pharmaceuticals Limited has informed the Exchange that Record date for the purpose of Dividend is 16-Feb-2022.
AstraZeneca Pharma India Limited has informed the Exchange that Ms. Kimsuka Narsimhan (DIN: 02102783), Independent Director of the Company, retired as Director of the Company, upon completion of her term of office, at the close of business hours on February 1, 2022.

IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132 (Member ID - NSE: 10975 BSE: 179 MCX: 55995 NCDEX: 01249), DP SEBI Reg. No. IN-DP-185-2016, IA SEBI Regn. No: INA000000623, Merchant Banker SEBI Regn. No. INM000010940, RA SEBI Regn. No: INH000000248, BSE Enlistment Number (RA): 5016, AMFI-Registered Mutual Fund Distributor & SIF Distributor
ARN NO : 47791 (Date of initial registration – 17/02/2007; Current validity of ARN – 08/02/2027), PFRDA Reg. No. PoP 20092018, IRDAI Corporate Agent (Composite) : CA1099

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.